 | Up a level |
Brouwer, N P M; Khan, A; Bokhorst, J M; Ayatollahi, F; Hay, J; Ciompi, F; Simmer, F; Hugen, N; de Wilt, J H W; Berger, M D; Lugli, A; Zlobec, I; Edwards, J; Nagtegaal, I D (2024). The complexity of shapes; how the circularity of tumor nodules impacts prognosis in colorectal cancer. Modern pathology, 37(1), p. 100376. Elsevier 10.1016/j.modpat.2023.100376
Karamitopoulou, Evanthia; Zlobec, I; Born, D; Kondi-Pafiti, A; Lykoudis, P; Mellou, A; Gennatas, K; Gloor, B; Lugli, A (2013). Tumour budding is a strong and independent prognostic factor in pancreatic cancer. European journal of cancer, 49(5), pp. 1032-9. Amsterdam: Elsevier 10.1016/j.ejca.2012.10.022
Lugli, A; Karamitopoulou, Eva; Zlobec, I (2012). Tumour budding: a promising parameter in colorectal cancer. British journal of cancer, 106(11), pp. 1713-7. Basingstoke: Nature Publishing Group 10.1038/bjc.2012.127
Salm, F; Cwiek, P; Ghosal, A; Lucia Buccarello, A; Largey, F; Wotzkow, C; Höland, K; Styp-Rekowska, B; Djonov, V; Zlobec, I; Bodmer, N; Gross, N; Westermann, F; Schäfer, S C; Arcaro, A (2012). RNA interference screening identifies a novel role for autocrine fibroblast growth factor signaling in neuroblastoma chemoresistance. Oncogene, 32(34), pp. 3944-3953. Basingstoke, UK: Nature Publishing Group 10.1038/onc.2012.416
Cindolo, L; Cantile, M; Franco, R; Chiodini, P; Schiavo, G; Forte, I; Zlobec, I; Salzano, L; Botti, G; Gidaro, S; Terracciano, L; Cillo, C (2011). Parallel determination of NeuroD1, chromogranin-A, KI67 and androgen receptor expression in surgically treated prostate cancers. International Braz J Urol - official journal of the Brazilian Society of Urology, 37(1), pp. 57-66. Rio de Janerio: Brazilian Society of Urology 10.1590/S1677-55382011000700008
Lugli, A; Zlobec, I (2011). Gene signatures in colorectal cancer. In: Russo A, Iacobelli S (ed.) Diagnostic, prognostic and therapeutic value of gene signatures (pp. 115-136). Berlin-Heidelberg: Springer
Dawson, H; Koelzer, V; Inderbitzin, D; Lugli, A; Zlobec, I (2012). Cdx2 loss is a frequent indicator of high-level microsatellite instability (MSI-H) status in colorectal cancer. In: Tag der Klinischen Forschung 2012. Tag der Klinischen Forschung 2012
